• Valbiotis received two orders totaling 50,000 boxes of 90 capsules from its Chinese joint venture, covering all four PRO products.
• The first order was delivered in late October, contributing to second-half 2026 revenue.
• The second order is in production for shipment within weeks; revenue recognition depends on shipment by December 31.
• Consumer sales in China are expected by year-end through cross-border e-commerce platforms, at prices significantly above those in France.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valbiotis SA published the original content used to generate this news brief via EQS News (Ref. ID: fr_reg_2426754_fr) on November 02, 2026, and is solely responsible for the information contained therein.